The Department of Health (DoH) recently released a report that reviewed and reported on barriers encountered by patients when trying to access to medicinal cannabis in Australia. There are many contributors who will understandably focus on the patient side, but few will identify the points of interest for medicinal cannabis manufacturers and distributors and how…
With the legalisation of cultivation and export of medicinal cannabis products within Australia, many growers and companies producing medicinal cannabis products have set their interest in exporting their excess products to other parts of the world. A market of particular interest is Germany, in which 60,000 patients registered for medicinal cannabis products in 2019, which…
Unlike other markets (i.e. Canada, the US, the UK and parts of Europe) CBD is more strictly controlled in Australia, and the pure extracts (as well as any associated products) are considered Schedule 4 prescription drugs under the Poisons Standard. One of the top questions I get asked as a medicinal cannabis consultant is: “Can…
Recent presentations given about South African Medicinal Cannabis CannaTech and Sandton Cannabis Expo 2019 During the month of November 2019, the PharmOut team attended the CannaTech Conference in Cape Town, South Africa for 2 days to learn more about the South African Medicinal Cannabis market. Following on from that, the team headed up to the…
Crop Risks: Outdoor cannabis crop risks compared to indoor growing (protected cropping) What are the dangers and potential disasters of outdoor medicinal cannabis cultivation? Outdoor medicinal cannabis cultivation may offer lower-cost production options for commercial-scale operators…but what are the risks? Operational costs for outdoor cannabis crops tend to be significantly lower than indoor cultivation settings….
Please complete the form on the contact us page. We will get back to you within one business day.
Phone: +61 3 9887 6412
Email: info@pharmout.net
